Eric Langer

CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China

Continuous Bioprocessing growing quickly, but from a low base, with virtually all manufacturers now using at least some single use…

4 years ago

bioLIVE to introduce global biopharma country ranking

Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness Amsterdam, March 29, 2018: bioLIVE – the UBM…

7 years ago